Active surveillance cultures and decolonization to reduce staphylococcus aureus infections in the neonatal intensive care unit

Infection Control and Hospital Epidemiology

Volumn 37, Issue 4, 2016, Pages 381-387

  Popoola, Victor O ^a   Colantuoni, Elizabeth ^b   Suwantarat, Nuntra ^a   Pierce, Rebecca ^b   Carroll, Karen C ^b   Aucott, Susan W ^a   Milstone, Aaron M ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^c JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORHEXIDINE; PSEUDOMONIC ACID; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATE; DISEASE SURVEILLANCE; FEMALE; HEALTHCARE ASSOCIATED INFECTION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; NEWBORN; NEWBORN INTENSIVE CARE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS INFECTION; TERTIARY HEALTH CARE; CROSS INFECTION; INFECTION CONTROL; ISOLATION AND PURIFICATION; MARYLAND; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NEONATAL INTENSIVE CARE UNIT; PROCEDURES; REGRESSION ANALYSIS; STAPHYLOCOCCAL INFECTIONS;

ANTI-BACTERIAL AGENTS; CROSS INFECTION; FEMALE; HUMANS; INCIDENCE; INFANT, NEWBORN; INFECTION CONTROL; INTENSIVE CARE UNITS, NEONATAL; MALE; MARYLAND; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MUPIROCIN; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; TERTIARY HEALTHCARE;

EID: 84961744597     PISSN: 0899823X     EISSN: 15596834     Source Type: Journal    
DOI: 10.1017/ice.2015.316     Document Type: Article

References (36)

1. Chu A, Hageman JR, Schreiber M, Alexander K. Antimicrobial therapy and late onset sepsis. NeoReviews 2012; 13: e94-e102
2. Stoll BJ, Hansen N, Fanaroff AA, et al. Late-onset sepsis in very low birth weight neonates: the experience of the NICHD Neonatal Research Network. Pediatrics 2002; 110: 285-291
3. Shane AL, Hansen NI, Stoll BJ, et al. Methicillin-resistant and susceptible Staphylococcus aureus bacteremia and meningitis in preterm infants. Pediatrics 2012; 129: e914-e922
4. Popoola VO, Budd A, Wittig SM, et al. MRSA transmission and infections in a neonatal intensive care unit despite active surveillance cultures and decolonization-challenges for infection prevention. Infect Control Hosp Epidemiol 2014; 35: 412-418
5. Klevens RM, Edwards JR, Richards CL Jr, et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep 2007; 122: 160-166
6. Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics 2004; 114: 348-355
7. Sohn AH, Garrett DO, Sinkowitz-Cochran RL, et al. Prevalence of nosocomial infections in neonatal intensive care unit patients: results from the first national point-prevalence survey. J Pediatr 2001; 139: 821-827
8. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004; 292: 2357-2365
9. Schlapbach LJ, Aebischer M, Adams M, et al. Impact of sepsis on neurodevelopmental outcome in a Swiss national cohort of extremely premature infants. Pediatrics 2011; 128: e348-e357
10. Hornik CP, Fort P, Clark RH, et al. Early and late onset sepsis in very-low-birth-weight infants from a large group of neonatal intensive care units. Early Hum Dev 2012; 88: S69-S74
11. Hocevar SN, Edwards JR, Horan TC, Morrell GC, Iwamoto M, Lessa FC. Device-associated infections among neonatal intensive care unit patients: incidence and associated pathogens reported to the National Healthcare Safety Network, 2006-2008. Infect Control Hosp Epidemiol 2012; 33: 1200-1206
12. Huang YC, Lien RI, Su LH, Chou YH, Lin TY. Successful control of methicillin-resistant Staphylococcus aureus in endemic neonatal intensive care units-a 7-year campaign. PLoS One 2011; 6: e23001
13. Nelson MU, Bizzarro MJ, Baltimore RS, Dembry LM, Gallagher PG. Clinical and molecular epidemiology of methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit in the decade following implementation of an active detection and isolation program. J Clin Microbiol 2015; 53: 2492-2501
14. Gerber SI, Jones RC, Scott MV, et al. Management of outbreaks of methicillin-resistant Staphylococcus aureus infection in the neonatal intensive care unit: a consensus statement. Infect Control Hosp Epidemiol 2006; 27: 139-145
15. Popoola VO, Milstone AM. Decolonization to prevent Staphylococcus aureus transmission and infections in the neonatal intensive care unit. J Perinatol 2014; 34: 805-810
16. Carey AJ, Duchon J, Della-Latta P, Saiman L. The epidemiology of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in a neonatal intensive care unit, 2000-2007. J Perinatol 2010; 30: 135-139
17. Kuint J, Barzilai A, Regev-Yochay G, Rubinstein E, Keller N, Maayan-Metzger A. Comparison of community-acquired methicillin-resistant Staphylococcus aureus bacteremia to other staphylococcal species in a neonatal intensive care unit. Eur J Pediatr 2007; 166: 319-325
18. GrahamPL 3rd, Morel AS, Zhou J, et al. Epidemiology of methicillinsusceptible Staphylococcus aureus in the neonatal intensive care unit. Infect Control Hosp Epidemiol 2002; 23: 677-682
19. Ericson JE, Popoola VO, Smith PB, et al. Burden of invasive Staphylococcus aureus infections in hospitalized infants [published online October 19, 2015]. JAMA Pediatr 2015: 1-8
20. Milstone AM, Budd A, Shepard JW, et al. Role of decolonization in a comprehensive strategy to reduce methicillin-resistant Staphylococcus aureus infections in the neonatal intensive care unit: an observational cohort study. Infect Control Hosp Epidemiol 2010; 31: 558-560
21. Centers for Disease Control and Prevention (CDC)/National Healthcare Safety Network (NHSN). Surveillance definitions for specific types of infections. CDC website. http://www.cdc.gov/nhsn/pdfs/validation/2013/2013-psc-manual-validate.pdf. Published 2013. Accessed November 7, 2013
22. Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing: 24th informational supplement. CLSI document. Wayne, PA: CLSI, 2014: M100-S24
23. Suwantarat N, Carroll KC, Tekle T, Ross T, Popoola VO, Milstone AM. Low prevalence of mupirocin resistance among hospital-acquired methicillin-resistant Staphylococcus aureus isolates in a neonatal intensive care unit with an active surveillance cultures and decolonization program. Infect Control Hosp Epidemiol 2015; 36: 232-234
24. Linden A. itsa: Stata module for conducting interrupted time series analysis for single and multiple groups. Linden Consulting website. http://lindenconsulting.org/stats.html. Published 2014
25. Khoury J, Jones M, Grim A, DunneWMJr, Fraser V. Eradication of methicillin-resistant Staphylococcus aureus from a neonatal intensive care unit by active surveillance and aggressive infection control measures. Infect Control Hosp Epidemiol 2005; 26: 616-621
26. Calfee DP, Salgado CD, Milstone AM, et al. Strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in acute care hospitals: 2014 update. Infect Control Hosp Epidemiol 2014; 35: S108-S132
27. Nelson MU, Bizzarro MJ, Dembry LM, Baltimore RS, Gallagher PG. One size does not fit all: why universal decolonization strategies to prevent methicillin-resistant Staphylococcus aureus colonization and infection in adult intensive care units may be inappropriate for neonatal intensive care units. J Perinatol 2014; 34: 653-655
28. Delaney HM, Wang E, Melish M. Comprehensive strategy including prophylactic mupirocin to reduce Staphylococcus aureus colonization and infection in high-risk neonates. J Perinatol 2013; 33: 313-318
29. Hitomi S, Kubota M, Mori N, et al. Control of a methicillinresistant Staphylococcus aureus outbreak in a neonatal intensive care unit by unselective use of nasal mupirocin ointment. J Hosp Infect 2000; 46: 123-129
30. Walker ES, Vasquez JE, Dula R, Bullock H, Sarubbi FA. Mupirocinresistant, methicillin-resistant Staphylococcus aureus: does mupirocin remain effective? Infect Control Hosp Epidemiol 2003; 24: 342-346
31. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17: 811-813
32. Jones JC, Rogers TJ, Brookmeyer P, et al. Mupirocin resistance in patients colonized withmethicillin-resistant Staphylococcus aureus in a surgical intensive care unit. Clin Infect Dis 2007; 45: 541-547
33. Choudhury S, Krishnan PU, Ang B. Prevalence of high-level mupirocin resistance among meticillin-resistant Staphylococcus aureus isolates in a tertiary care hospital in Singapore. J Hosp Infect 2012; 82: 56-57
34. You JH, Chan CY, Wong MY, Ip M. Active surveillance and decolonization of methicillin-resistant Staphylococcus aureus on admission to neonatal intensive care units in Hong Kong: a cost-effectiveness analysis. Infect Control Hosp Epidemiol 2012; 33: 1024-1030
35. Carey AJ.War on Staphylococcus aureus. J Perinatol 2014; 34: 803-804
36. Huang SS, Septimus E, Kleinman K, et al. Targeted versus universal decolonization to prevent ICU infection. N Engl J Med 2013; 368: 2255-2265